Brief: Cue Biopharma Inc - Lucinda Warren To Continue As Chief Financial And Business Officer - SEC Filing
27/03/2026 20:13
March 27 (Reuters) - Cue Biopharma Inc CUE.O: CUE BIOPHARMA INC - LUCINDA WARREN TO CONTINUE AS CHIEF FINANCIAL AND BUSINESS OFFICER - SEC FILING Source text: [ID:n0001193125-26-128993] Further company coverage: CUE.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cue Biopharma
See all newsU.S. STOCKS ON THE MOVE-Insmed, Marvell, Meta
US STOCKS ON THE MOVE-Meta, Marvell Technology, Insmed
U.S. STOCKS ON THE MOVE-Accenture, Arhaus, Alkermes
Cue Biopharma surges after positive results from mid-stage study for CUE-221
Brief: Cue Biopharma Announces Positive Topline Results From Cue-221 Phase 2 Study In Chronic Spontaneous Urticaria